These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 30179899)

  • 21. Clinical and molecular characterisation of hereditary and sporadic metastatic colorectal cancers harbouring microsatellite instability/DNA mismatch repair deficiency.
    Cohen R; Buhard O; Cervera P; Hain E; Dumont S; Bardier A; Bachet JB; Gornet JM; Lopez-Trabada D; Dumont S; Kaci R; Bertheau P; Renaud F; Bibeau F; Parc Y; Vernerey D; Duval A; Svrcek M; André T
    Eur J Cancer; 2017 Nov; 86():266-274. PubMed ID: 29055842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns and prognostic relevance of PD-1 and PD-L1 expression in colorectal carcinoma.
    Lee LH; Cavalcanti MS; Segal NH; Hechtman JF; Weiser MR; Smith JJ; Garcia-Aguilar J; Sadot E; Ntiamoah P; Markowitz AJ; Shike M; Stadler ZK; Vakiani E; Klimstra DS; Shia J
    Mod Pathol; 2016 Nov; 29(11):1433-1442. PubMed ID: 27443512
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Colorectal carcinomas with KRAS codon 12 mutation are associated with more advanced tumor stages.
    Li W; Qiu T; Zhi W; Shi S; Zou S; Ling Y; Shan L; Ying J; Lu N
    BMC Cancer; 2015 May; 15():340. PubMed ID: 25929517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas.
    Blanes A; Diaz-Cano SJ
    World J Gastroenterol; 2006 Oct; 12(37):5932-40. PubMed ID: 17009390
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High frequency of KRAS mutation in early onset colorectal adenocarcinoma: implications for pathogenesis.
    Watson R; Liu TC; Ruzinova MB
    Hum Pathol; 2016 Oct; 56():163-70. PubMed ID: 27346571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Prevalence and Prognosis of Microsatellite Instability-High/Mismatch Repair-Deficient Colorectal Adenocarcinomas in the United States.
    Gutierrez C; Ogino S; Meyerhardt JA; Iorgulescu JB
    JCO Precis Oncol; 2023 Jan; 7():e2200179. PubMed ID: 36716414
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma.
    Hall G; Clarkson A; Shi A; Langford E; Leung H; Eckstein RP; Gill AJ
    Pathology; 2010; 42(5):409-13. PubMed ID: 20632815
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.
    Mills AM; Sloan EA; Thomas M; Modesitt SC; Stoler MH; Atkins KA; Moskaluk CA
    Am J Surg Pathol; 2016 Feb; 40(2):155-65. PubMed ID: 26523542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of grading based on the counting of poorly differentiated clusters in colorectal mucinous adenocarcinoma.
    Barresi V; Reggiani Bonetti L; Ieni A; Domati F; Tuccari G
    Hum Pathol; 2015 Nov; 46(11):1722-9. PubMed ID: 26344416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential diagnostic and functional role of the multi-marker phenotype CDX2/CK20/CK7 in colorectal cancer stratified by mismatch repair status.
    Lugli A; Tzankov A; Zlobec I; Terracciano LM
    Mod Pathol; 2008 Nov; 21(11):1403-12. PubMed ID: 18587323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ARID1A expression in early stage colorectal adenocarcinoma: an exploration of its prognostic significance.
    Lee LH; Sadot E; Ivelja S; Vakiani E; Hechtman JF; Sevinsky CJ; Klimstra DS; Ginty F; Shia J
    Hum Pathol; 2016 Jul; 53():97-104. PubMed ID: 26980037
    [TBL] [Abstract][Full Text] [Related]  

  • 32. DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases.
    Agaram NP; Shia J; Tang LH; Klimstra DS
    Am J Clin Pathol; 2010 May; 133(5):772-80. PubMed ID: 20395525
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mismatch Repair Status Correlates with Survival in Young Adults with Metastatic Colorectal Cancer.
    van der Heide DM; Turaga KK; Chan CHF; Sherman SK
    J Surg Res; 2021 Oct; 266():104-112. PubMed ID: 33989889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial carcinomas in women aged 40 years and younger: tumors associated with loss of DNA mismatch repair proteins comprise a distinct clinicopathologic subset.
    Garg K; Shih K; Barakat R; Zhou Q; Iasonos A; Soslow RA
    Am J Surg Pathol; 2009 Dec; 33(12):1869-77. PubMed ID: 19898223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
    Karahan B; Argon A; Yıldırım M; Vardar E
    Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA mismatch repair deficiency but not ARID1A loss is associated with prognosis in small intestinal adenocarcinoma.
    González I; Goyal B; Xia MD; Pai RK; Ma C
    Hum Pathol; 2019 Mar; 85():18-26. PubMed ID: 30381262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Automated Quantitation of CD8-positive T Cells Predicts Prognosis in Colonic Adenocarcinoma With Mucinous, Signet Ring Cell, or Medullary Differentiation Independent of Mismatch Repair Protein Status.
    Hartman DJ; Frank M; Seigh L; Choudry H; Pingpank J; Holtzman M; Bartlett D; Bahary N; Pantanowitz L; Pai RK
    Am J Surg Pathol; 2020 Jul; 44(7):991-1001. PubMed ID: 32205483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mucinous differentiation in colorectal cancer--indicator of poor prognosis?
    Langner C; Harbaum L; Pollheimer MJ; Kornprat P; Lindtner RA; Schlemmer A; Vieth M; Rehak P
    Histopathology; 2012 Jun; 60(7):1060-72. PubMed ID: 22348346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histopathology and mismatch repair status of 458 consecutive colorectal carcinomas.
    Wright CL; Stewart ID
    Am J Surg Pathol; 2003 Nov; 27(11):1393-406. PubMed ID: 14576472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-free DNA blood levels in colorectal cancer patients do not correlate with mismatch repair-proficiency.
    Lazarev I; Leibovitch L; Czeiger D; Sion-Vardi N; Geffen DB; Douvdevani A; Ariad S
    In Vivo; 2014; 28(3):349-54. PubMed ID: 24815837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.